Chemoinformaics analysis of VALERENOL-HEXANDRATE
| Molecular Weight | 220.356 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 11 |
| Exact Molecular Weight | 220.183 | nRing | 2 |
| Solubility: LogS | -3.023 | nHRing | 0 |
| Solubility: LogP | 3.296 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 1 | BPOL | 24.077 |
| QED | 0.704 |
| Synth | 4.19 |
| Natural Product Likeliness | 2.731 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.002 |
| HIA | 0.01 |
| CACO-2 | -4.421 |
| MDCK | 0.0000152 |
| BBB | 0.803 |
| PPB | 0.973903 |
| VDSS | 5.422 |
| FU | 0.023067 |
| CYP1A2-inh | 0.523 |
| CYP1A2-sub | 0.64 |
| CYP2c19-inh | 0.125 |
| CYP2c19-sub | 0.808 |
| CYP2c9-inh | 0.197 |
| CYP2c9-sub | 0.349 |
| CYP2d6-inh | 0.01 |
| CYP2d6-sub | 0.233 |
| CYP3a4-inh | 0.613 |
| CYP3a4-sub | 0.425 |
| CL | 6.83 |
| T12 | 0.095 |
| hERG | 0.009 |
| Ames | 0.033 |
| ROA | 0.136 |
| SkinSen | 0.072 |
| Carcinogencity | 0.353 |
| EI | 0.306 |
| Respiratory | 0.735 |
| NR-Aromatase | 0.008 |
| Antiviral | Yes |
| Prediction | 0.890264 |